Purespring is committed to respecting and promoting human rights across all areas of our business, from research and clinical development to supply chain partnerships. We align with international standards, including the Universal Declaration of Human Rights, ILO principles, and the UN Guiding Principles on Business and Human Rights, ensuring our operations are ethical, fair, and respectful.

We integrate human rights into our work through due diligence, supplier risk assessments, and engagement with employees, participants, communities, and partners. With clear expectations for suppliers, strong grievance mechanisms, and zero tolerance for modern slavery, discrimination, and corruption, we aim to safeguard human rights while advancing gene therapies responsibly and sustainably.